Mechanotransduction and the extracellular matrix: Key drivers of lung pathologies and drug responsiveness-Reference-Cited by-同舟云学术

Mechanotransduction and the extracellular matrix: Key drivers of lung pathologies and drug responsiveness

Published:2024-05 Issue: Volume: Page:116255
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Burgess Janette K^ORCID,Gosens Reinoud

Publisher

Elsevier BV

Reference188 articles.

1. Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history;Sgalla;Respirol,2016

2. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology;Vancheri;Eur. Respir. J.,2010

3. Eurostat, Respiratory Disease Statistics, 2021. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Respiratory_diseases_statistics (Accessed 04 Nov 2021 2021).

4. Respiratory health and disease in Europe: the new European Lung White Book;Gibson;Eur. Respir. J.,2013

5. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;Vos;Lancet,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting tumor mechanomedicine for lung cancer treatment;Cancer Letters;2024-11

2. Adam19 Deficiency Impacts Pulmonary Function: Human GWAS Follow-up in a Mouse Knockout Model;Lung;2024-08-17

3. An introduction to the special issue “Sam Enna legacy of excellence”;Biochemical Pharmacology;2024-08

4. Cancer treatments as paradoxical catalysts of tumor awakening in the lung;Cancer and Metastasis Reviews;2024-07-04